Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Danaher Corporation announced that Danaher has entered into a definitive agreement to acquire privately-held Aldevron, for a cash purchase price of approximately $9.6 billion. Danaher expects to finance the acquisition using cash on hand and/or ...
read more
Coriolis Pharma, a globally operating service provider in formulation research and development of biopharmaceutical drugs, announced the expansion of its ATMP development facilities under biosafety level S2 (BSL2).
read more
Vectura Group plc announced it has signed an agreement with Incannex Healthcare Limited, an Australian cannabinoid medicines development company, to provide pre-clinical development services for IHL-216A, Incannex’s proprietary inhaled drug product ...
read more
APC Ltd, an Irish pharmaceutical research and development company, is investing €25M and creating 120 jobs through the formation of a ‘Global Centre of Excellence for Vaccine and Advanced Therapeutic Research and Manufacturing’.
read more
Solvias, a large independent analytical testing, contract research, development and manufacturing company, announced that it has acquired Canton, Mass.-based Chemic Laboratories, Inc. (Chemic). With this acquisition, Solvias gains a strong foothold ...
read more
Eurofins Discovery and ImmunoPrecise Antibodies, the announced a commercial collaboration. Leveraging complementary strengths in Eurofins Discovery's in vitro pharmacology services and ImmunoPrecise's in vivo characterization and discovery ...
read more
Chemomab Therapeutics,Ltd., a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrosis-related diseases with high unmet need, and AGC Biologics, a global Biopharmaceutical Contract Development ...
read more
Genezen Laboratories, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) focused on early-phase process development, vector production and analytical testing services, has broken ground on a new multiphase master...
read more
CellPoint, a cell therapy company developing CAR-T therapeutics for use at the point-of-care, announces an agreement with Lonza's Personalized Medicine Business Unit to employ Lonza's Cocoon® Platform for clinical manufacturing of CellPoint's CAR-T ...
read more
Breckenridge Pharmaceutical, Inc. announced the signing of a multi-product agreement with Aggrega Pharma, LLC. under which Aggrega will develop, manufacture and supply pharmaceutical products for marketing, sale and distribution by Breckenridge.
read more
Novasep, a supplier of services and technologies for the life sciences industry, announced a €6.1 million investment at its Mourenx facility(Pyrénées-Atlantiques – France). This investment will modernize its API manufacturing facility.
read more
Veradigm®, a healthcare data and technology company and business unit of Allscripts Healthcare Solutions, and PRA Health Sciences Inc., a global contract research organization, announced the creation of the industry’s leading electronic healthcare ...
read more
Takara Bio Inc. announced a License and Supply Agreement with BioNTech Cell & Gene Therapies GmbH ("BioNTech"), a BioNTech SE company (www.BioNTech.de), Germany, under which Takara Bio grants BioNTech a commercial license to use applicable patents ...
read more
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that it has reached an agreement to acquire ...
read more
Samsung Biologics, a contract development and manufacturing organization (CMDO), celebrated the one-year mark of Live Virtual Tour (LVT), a platform to provide remote site inspections for clients and regulatory agencies. The tool was developed and ...
read more